🎉 Health Canada Provides a No Objection Letter for ATMA’s N500 Phase II Clinical Trial Application

Free Webinar

ATMA Academy hosts Dr. Rakesh and Dr. Saundra Jain

With Health Canada ammending the Special Access Program, now is the time to see how Psychedelic-Assisted Therapy can help treatment resistant patients in your practice. Industry leaders share how humility and competence are key to psychedelic therapy.

We will never use your email for any other purpose, than keeping you up to date about ATMA products.

Scroll to Top